Home/Filings/4/0001437749-17-000196
4//SEC Filing

NovaBay Pharmaceuticals, Inc. 4

Accession 0001437749-17-000196

$NBYCIK 0001389545operating

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 6:29 PM ET

Size

5.2 KB

Accession

0001437749-17-000196

Insider Transaction Report

Form 4
Period: 2017-01-03
WU MIJIA
Director
Transactions
  • Award

    stock option (right to buy)

    2017-01-03+15,24515,245 total
    Exercise: $3.24From: 2017-01-03Exp: 2027-01-03Common Stock (15,245 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the 2007 Omnibus Incentive Plan and the 2017 NonEmployee Director Compensation Plan
  • [F2]Stock options will vest in equal monthly installments over the remainder of the year starting from the date of grant

Documents

1 file

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001389545

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:29 PM ET
Size
5.2 KB